Novartis AG
SGLT1/2 INHIBITOR LIK066 FOR TREATING OBESITY
Last updated:
Abstract:
The present invention is drawn to methods for effecting weight loss, e.g.. in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se.
Status:
Application
Type:
Utility
Filling date:
2 Mar 2018
Issue date:
23 Apr 2020